Notice: This guidance is under active development by NHS England and content may be added or updated on a regular basis.
HTML View
ValueSet 'EnglandHighRiskReferralReasonScreening'
Version | 0.1.0 |
Published by | NHS England |
Status | Draft (since 2024-11-22) |
Experimental | False |
A ValueSet used to indicate which higher risk codes are associated with a patient. The codes and their description are datasets definition from the Breast Screening Service(BS-Select).
Contact Information
NHS England
Email: interoperabilityteam@nhs.net
Expansion
This expansion was generated on 2024-11-22T12:00:00+00:00
Code | System | Display |
---|---|---|
AT-heterozygotes | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | A-T Heterozygotes |
AT-homozygotes | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | A-T Homozygotes |
BRCA-risk | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | BRCA1/BRCA2/PALB2 (8% 10-Year Risk) |
BRCA-tested | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | BRCA1/BRCA2/PALB2 Tested |
HR-gene-untested | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | HR Gene Untested |
other-gene-mutations | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | Other Gene Mutations |
radiotherapy-below-30 | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | Radiotherapy Below Aged 30 |
radiotherapy-lower | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | Radiotherapy To Breast Tissue Aged 10-19 |
radiotherapy-upper | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | Radiotherapy To Breast Tissue Aged 20-35 |
risk-equivalent | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | Risk Equivalent, Not Tested |
TP53 | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason | TP53 (Li-Fraumeni) Syndrome |
Table View
ValueSet.id[0] | England-HighRiskReferralReasonScreening |
ValueSet.url[0] | https://fhir.nhs.uk/England/ValueSet/England-HighRiskReferralReasonScreening |
ValueSet.version[0] | 0.1.0 |
ValueSet.name[0] | EnglandHighRiskReferralReasonScreening |
ValueSet.title[0] | England High Risk Referral Reason Screening |
ValueSet.status[0] | draft |
ValueSet.experimental[0] | False |
ValueSet.date[0] | 2024-11-22 |
ValueSet.publisher[0] | NHS England |
ValueSet.contact[0].name[0] | NHS England |
ValueSet.contact[0].telecom[0].system[0] | |
ValueSet.contact[0].telecom[0].value[0] | interoperabilityteam@nhs.net |
ValueSet.contact[0].telecom[0].use[0] | work |
ValueSet.contact[0].telecom[0].rank[0] | 1 |
ValueSet.description[0] | A ValueSet used to indicate which higher risk codes are associated with a patient. The codes and their description are datasets definition from the Breast Screening Service(BS-Select). |
ValueSet.copyright[0] | Copyright © 2024+ NHS England Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html. |
ValueSet.expansion[0].timestamp[0] | 2024-11-22T12:00:00+00:00 |
ValueSet.expansion[0].contains[0].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[0].code[0] | AT-heterozygotes |
ValueSet.expansion[0].contains[0].display[0] | A-T Heterozygotes |
ValueSet.expansion[0].contains[1].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[1].code[0] | AT-homozygotes |
ValueSet.expansion[0].contains[1].display[0] | A-T Homozygotes |
ValueSet.expansion[0].contains[2].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[2].code[0] | BRCA-risk |
ValueSet.expansion[0].contains[2].display[0] | BRCA1/BRCA2/PALB2 (8% 10-Year Risk) |
ValueSet.expansion[0].contains[3].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[3].code[0] | BRCA-tested |
ValueSet.expansion[0].contains[3].display[0] | BRCA1/BRCA2/PALB2 Tested |
ValueSet.expansion[0].contains[4].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[4].code[0] | HR-gene-untested |
ValueSet.expansion[0].contains[4].display[0] | HR Gene Untested |
ValueSet.expansion[0].contains[5].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[5].code[0] | other-gene-mutations |
ValueSet.expansion[0].contains[5].display[0] | Other Gene Mutations |
ValueSet.expansion[0].contains[6].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[6].code[0] | radiotherapy-below-30 |
ValueSet.expansion[0].contains[6].display[0] | Radiotherapy Below Aged 30 |
ValueSet.expansion[0].contains[7].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[7].code[0] | radiotherapy-lower |
ValueSet.expansion[0].contains[7].display[0] | Radiotherapy To Breast Tissue Aged 10-19 |
ValueSet.expansion[0].contains[8].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[8].code[0] | radiotherapy-upper |
ValueSet.expansion[0].contains[8].display[0] | Radiotherapy To Breast Tissue Aged 20-35 |
ValueSet.expansion[0].contains[9].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[9].code[0] | risk-equivalent |
ValueSet.expansion[0].contains[9].display[0] | Risk Equivalent, Not Tested |
ValueSet.expansion[0].contains[10].system[0] | https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason |
ValueSet.expansion[0].contains[10].code[0] | TP53 |
ValueSet.expansion[0].contains[10].display[0] | TP53 (Li-Fraumeni) Syndrome |
XML View
<ValueSet xmlns="http://hl7.org/fhir"> <id value="England-HighRiskReferralReasonScreening" /> <url value="https://fhir.nhs.uk/England/ValueSet/England-HighRiskReferralReasonScreening" /> <version value="0.1.0" /> <name value="EnglandHighRiskReferralReasonScreening" /> <title value="England High Risk Referral Reason Screening" /> <status value="draft" /> <experimental value="false" /> <date value="2024-11-22" /> <publisher value="NHS England" /> <contact> <name value="NHS England" /> <telecom> <system value="email" /> <value value="interoperabilityteam@nhs.net" /> <use value="work" /> <rank value="1" /> </telecom> </contact> <description value="A ValueSet used to indicate which higher risk codes are associated with a patient. The codes and their description are datasets definition from the Breast Screening Service(BS-Select)." /> <copyright value="Copyright © 2024+ NHS England Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html." /> <expansion> <timestamp value="2024-11-22T12:00:00+00:00" /> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="AT-heterozygotes" /> <display value="A-T Heterozygotes" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="AT-homozygotes" /> <display value="A-T Homozygotes" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="BRCA-risk" /> <display value="BRCA1/BRCA2/PALB2 (8% 10-Year Risk)" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="BRCA-tested" /> <display value="BRCA1/BRCA2/PALB2 Tested" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="HR-gene-untested" /> <display value="HR Gene Untested" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="other-gene-mutations" /> <display value="Other Gene Mutations" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="radiotherapy-below-30" /> <display value="Radiotherapy Below Aged 30" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="radiotherapy-lower" /> <display value="Radiotherapy To Breast Tissue Aged 10-19" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="radiotherapy-upper" /> <display value="Radiotherapy To Breast Tissue Aged 20-35" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="risk-equivalent" /> <display value="Risk Equivalent, Not Tested" /> </contains> <contains> <system value="https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason" /> <code value="TP53" /> <display value="TP53 (Li-Fraumeni) Syndrome" /> </contains> </expansion> </ValueSet>
JSON View
{ "resourceType": "ValueSet", "id": "England-HighRiskReferralReasonScreening", "url": "https://fhir.nhs.uk/England/ValueSet/England-HighRiskReferralReasonScreening", "version": "0.1.0", "name": "EnglandHighRiskReferralReasonScreening", "title": "England High Risk Referral Reason Screening", "status": "draft", "experimental": false, "date": "2024-11-22", "publisher": "NHS England", "contact": [ { "name": "NHS England", "telecom": [ { "system": "email", "value": "interoperabilityteam@nhs.net", "use": "work", "rank": 1 } ] } ], "description": "A ValueSet used to indicate which higher risk codes are associated with a patient. The codes and their description are datasets definition from the Breast Screening Service(BS-Select).", "copyright": "Copyright © 2024+ NHS England Licensed under the Apache License, Version 2.0 (the \"License\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \"AS IS\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html.", "expansion": { "timestamp": "2024-11-22T12:00:00+00:00", "contains": [ { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "AT-heterozygotes", "display": "A-T Heterozygotes" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "AT-homozygotes", "display": "A-T Homozygotes" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "BRCA-risk", "display": "BRCA1/BRCA2/PALB2 (8% 10-Year Risk)" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "BRCA-tested", "display": "BRCA1/BRCA2/PALB2 Tested" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "HR-gene-untested", "display": "HR Gene Untested" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "other-gene-mutations", "display": "Other Gene Mutations" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "radiotherapy-below-30", "display": "Radiotherapy Below Aged 30" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "radiotherapy-lower", "display": "Radiotherapy To Breast Tissue Aged 10-19" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "radiotherapy-upper", "display": "Radiotherapy To Breast Tissue Aged 20-35" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "risk-equivalent", "display": "Risk Equivalent, Not Tested" }, { "system": "https://fhir.nhs.uk/England/CodeSystem/England-ScreeningHighRiskReferralReason", "code": "TP53", "display": "TP53 (Li-Fraumeni) Syndrome" } ] } }